Asia Medical & Agricultural Laboratory & Research Center PCL

Asia Medical & Agricultural Laboratory & Research Center PCL maintains a strong liquidity position, with a current ratio of 4.78 and a cash and equivalents balance of 45.56 million THB. The company's debt-to-equity ratio is 0.03, indicating a conservative capital structure with minimal leverage. Free cash flow of 149.95 million THB supports operational flexibility and potential reinvestment. Profitability metrics show a return on equity of 26.34% and a return on assets of 22.48%, both significantly above the typical thresholds for the Business Support Services industry. The operating margin, calculated as operating income of 158.27 million THB divided by revenue of 491.01 million THB, is 32.23%, which is robust compared to industry medians. The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the latest financial data. This lack of diversification may expose the company to regional economic fluctuations, though the specific impact is not quantified in the available data. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue deltas reported in the outlook. Historical revenue of 491.01 million THB provides a baseline for future performance, though the absence of forward-looking guidance limits the ability to assess long-term growth potential. Risk factors are minimal, with low liquidity and dilution risk scores. No immediate filing-based liquidity or dilution flags were detected, and the company has not issued any recent dilutive instruments. The absence of dilution pressure is supported by the identical basic and diluted share counts of 420 million shares. Recent events include a single analyst recommendation of "Hold" with a mean price target of 4.30 THB. No strong buy or buy ratings were issued, and the company has not disclosed any material events in its recent filings or transcripts that would suggest a significant shift in business strategy or performance.